SCHEMBL5162498

SCHEMBL5162498

CCCCc1nc(N2CCNCC2)cc(C(F)(F)F)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 1/20 0.46
ADRB2 P07550 3/20 0.42
HTR2C P28335 3/20 0.42
ADRA2A P08913 1/20 0.42
AXL P30530 1/20 0.42
HRH1 P35367 1/20 0.42
HTR2B P41595 1/20 0.42
HTR6 P50406 1/20 0.42
MKNK1 Q9BUB5 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
ADRB1 P08588 4/20 0.40
CASP1 P29466 1/20 0.39
CASP4 P49662 1/20 0.39
CASP5 P51878 1/20 0.39
HRH4 Q9H3N8 1/20 0.38
NPSR1 Q6W5P4 1/20 0.36
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3655755 0.80 CETP (0.49) CETPHTR2CHTR6ADRB1CASP1
SCHEMBL5500376 0.80 DRD2 (0.46) DRD2DRD3
SCHEMBL2254829 0.79 ADRB2 (0.51) ADRB2HTR2CADRA2AAXLHRH1
SCHEMBL3653384 0.76 HRH4 (0.57) CETPHTR6ADRB1CASP1CASP4
SCHEMBL1045813 0.74 DRD2 (0.50) DRD2DRD3
SCHEMBL6224825 0.73 HRH3 (0.54) CETPHTR2CHTR6ADRB1HRH4
SCHEMBL9843933 0.71 GPR84 (0.37) NPSR1
SCHEMBL27454448 0.70 GABRA2 (0.36) CETPNPSR1
SCHEMBL30954210 0.70 ADRB1 (0.47) ADRB2HTR2CADRA2AAXLHRH1
SCHEMBL1764382 0.70 DRD2 (0.49) CASP1CASP4CASP5HRH4DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101511805-B As dopamine D3Novel carbonylated (aza) cyclohexanes with receptor ligands BIOPROJET SOC CIV 2013-10-30 CN disclosed
CN-101511805-A As dopamine D3Novel carbonylated (aza) cyclohexanes with receptor ligands BIOPROJET SOC CIV (FR) 2009-08-19 CN disclosed
EP-1763522-A1 PYRIDIN-2-ONE COMPOUNDS AND THEIR USE AS MODULATORS OF THE DOPAMINE D3 RECEPTOR Abbott GmbH & Co. KG (DE) 2007-03-21 EP disclosed
EP-1751116-A2 PYRIMIDINE COMPOUNDS AND USE THEREOF Abbott GmbH & Co. KG (DE) 2007-02-14 EP disclosed
WO-2005118558-A2 PYRIMIDINE COMPOUNDS AND USE THEREOF ABBOTT GMBH & CO. KG (DE) 2005-12-15 WO disclosed
WO-2005118571-A1 PYRIDIN-2-ONE COMPOUNDS AND THEIR USE AS MODULATORS OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO. KG (DE) 2005-12-15 WO disclosed
EP-1601659-A1 PYRIMIDIN-2-ONE COMPOUNDS AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS Abbott GmbH & Co. KG (DE) 2005-12-07 EP disclosed
WO-2004080981-A1 PYRIMIDIN-2-ONE COMPOUNDS AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS ABBOTT GMBH & CO. KG (DE) 2004-09-23 WO disclosed
CN-1267286-A 2-{3-[4-(2-t-butyl-6-trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate BASF AG (DE) 2000-09-20 CN disclosed